PPARA and fatty liver disease: We observed increases in both Ppara and Pparg mRNA expression in rats regardless of treatment with insulin and/or hCG, and this suggests that the induction of varying degrees of hepatic steatosis by the different treatments depends on the balance between PPARα and PPARβ activity.